FDA grants priority review to GI agent for controlling diarrhea in HIV/AIDS patients

Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology

View the original article here